[
  {
    "author": [
      {
        "family": "Company",
        "given": "Punta Alegre Sugar Company"
      },
      {
        "family": "Envelope",
        "given": "U.S."
      },
      {
        "family": "Company",
        "given": "John P.Chase"
      },
      {
        "given": "Philadelphia"
      },
      {
        "family": "Company",
        "given": "Norfolk Steamship"
      }
    ],
    "container-title": [
      "He became economic adviser to Thomas Dewey in 1940, Supt. of Banks for New York State from 1947-49, director of McGraw Hill, editor of the business magazine Business-week, director of Rockefeller's Chase Manhattan Bank"
    ],
    "location": [
      "New York Life, New York Telephone"
    ],
    "title": [
      "Amoskeag Company and William Whitmore Company. Another member of Ag & Chem was Elliott V. Bell, who was also director of the American Cancer Society. He had been a financial writer for the New York Times from 1929 to 1939, which gave him entree into the highest financial circles"
    ],
    "type": "chapter"
  },
  {
    "note": [
      "Merck (U.S.) $4.2 billion in sales."
    ],
    "title": [
      "The Drug Trust In 1987, the eighteen largest drug firms were ranked as follows: 1"
    ],
    "type": null
  },
  {
    "citation-number": [
      "2."
    ],
    "note": [
      "Glaxo Holdings (United Kingdom) $3.4 billion."
    ],
    "type": null
  },
  {
    "citation-number": [
      "3."
    ],
    "title": [
      "Hoffman LaRoche (Switzerland) $3.1 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Beckman",
        "given": "Smith Kline"
      }
    ],
    "citation-number": [
      "4."
    ],
    "title": [
      "$2.8 billion"
    ],
    "type": null
  },
  {
    "citation-number": [
      "5."
    ],
    "note": [
      "Ciba-Geigy (Switzerland) $2.7 billion."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Pfizer"
      }
    ],
    "citation-number": [
      "6."
    ],
    "title": [
      "$2.5 billion (Standard & Poor's gives its sales as $4 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "G",
        "given": "Hoechst A."
      }
    ],
    "citation-number": [
      "7."
    ],
    "title": [
      "$2.5 billion (Standard & Poor's lists its sales as $38 billion Deutschmarks"
    ],
    "type": null
  },
  {
    "citation-number": [
      "8."
    ],
    "title": [
      "American Home Products (U.S.) $2.4 billion ($4.93 billion according to Standard & Poor's"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Lilly"
      }
    ],
    "citation-number": [
      "9."
    ],
    "title": [
      "$2.3 billion ($3.72 billion Standard & Poor's"
    ],
    "type": null
  },
  {
    "citation-number": [
      "10."
    ],
    "note": [
      "Upjohn (U.S.) $2 billion."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Squibb"
      }
    ],
    "citation-number": [
      "11."
    ],
    "title": [
      "$2 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Johnson"
      },
      {
        "given": "Johnson"
      }
    ],
    "citation-number": [
      "12."
    ],
    "title": [
      "$1.9 billion"
    ],
    "type": null
  },
  {
    "citation-number": [
      "13."
    ],
    "note": [
      "Sandoz (Switzerland) $1.8 billion."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Myers",
        "given": "Bristol"
      }
    ],
    "citation-number": [
      "14."
    ],
    "title": [
      "$1.6 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Beecham"
      }
    ],
    "citation-number": [
      "15."
    ],
    "note": [
      "subsidiary—$2.6 billion pounds sterling as overall income)."
    ],
    "title": [
      "$1.4 billion (Standard & Poor's gives $1.4 billion in sales of the U.S"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "G",
        "given": "Bayer A."
      }
    ],
    "citation-number": [
      "16."
    ],
    "title": [
      "$1.4 billion (Standard & Poor's gives the figure as $45.9 billion Deutschmarks"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Syntex"
      }
    ],
    "citation-number": [
      "17."
    ],
    "title": [
      "$1.1 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lambert",
        "given": "Warner"
      }
    ],
    "citation-number": [
      "18."
    ],
    "title": [
      "$1.1 billion (Standard & Poor's gives the figure as $3.1 billion"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lucier",
        "given": "Francis P."
      },
      {
        "family": "Black",
        "particle": "chairman of"
      },
      {
        "family": "Decker",
        "given": "Donald P.McHenry"
      },
      {
        "family": "UN",
        "particle": "former U.S. Ambassador to the"
      },
      {
        "family": "Lewis",
        "given": "Andrew L.",
        "particle": "Other directors of Smith Kline are",
        "suffix": "Jr"
      }
    ],
    "date": [
      "1979"
    ],
    "note": [
      "R. Gordon McGovern, chairman of Campbell Soup; Ralph A. Pfeiffer, Jr., chairman of IBM World Trade Corporation, American International Far East Corporation, Riggs National Bank, and chairman U.S.-China Trade Commission; he is also vice chairman of the key foreign policy operation, Center for Strategic and International Studies, which was"
    ],
    "title": [
      "Coal Company, General Coal Company, INA Investment Securities, chairman of CIGNA's High Yield Fund, and Geothermal Resources International",
      "now international advisor to the Council on Foreign Relations, Trustee of Brookings Institution and the Carnegie Endowment for International Peace, Ford Foundation, and the super-secret Ditchley Foundation set up by W. Averell Harriman during World War II; McHenry is also a director of Coca Cola and International Paper; Carolyn K. Davis, who was dean of the school of nurses at University of Michigan 1973-75, Health and Human Services since 1981; she is also a director of Johns Hopkins",
      "chairman of Union Pacific, the basis of the Harriman fortune; he is director of Ford Motor, trustee in bankruptcy Reading Company, former chairman of Reagan's transition team and deputy director of the Republican National Committee"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "U.S. Public Health Service Pharmacy Board",
        "particle": "the"
      },
      {
        "family": "H",
        "given": "P."
      }
    ],
    "note": [
      "now operates as Bullen Management Company; Donald F. Hornig, professor and director of the"
    ],
    "title": [
      "Bullen, who was with IBM from 1946-71"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "G",
        "given": "American I."
      },
      {
        "family": "Switzerland",
        "given": "G.Chemie",
        "particle": "of"
      },
      {
        "family": "Gadow",
        "particle": "a subsidiary of I. G. Farben of Germany. It was headed by"
      },
      {
        "family": "Herman Schmitz. I. G",
        "particle": "brother-in-law of"
      }
    ],
    "container-title": [
      "G Farben's dyestuffs division, Baron George von Schnitzler, was related to the powerful von Rath family, the J. H. Stein Bankhaus which held Hitler's account and the von Mallinckrodt family, the founders of the drug firm in the United States"
    ],
    "note": [
      "Like other I. G. officials, he had become an enthusiastic supporter of the Hitler regime. I. G. Farben gave four and a half million Reichsmarks to the"
    ],
    "title": [
      "changed its name to General Aniline and Film during the Second World War, but it was still wholly owned by I",
      "Farben's international agreements directly affected the U.S. war effort, because they set limits on U.S. supplies of magnesium, synthetic rubber and crucial medical supplies. The director of I"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "cartel",
        "given": "I.G.",
        "particle": "As the world's pre-eminent"
      }
    ],
    "container-title": [
      "From"
    ],
    "date": [
      "1908"
    ],
    "note": [
      "G. held back its discovery of sulfanilimide, which"
    ],
    "pages": [],
    "title": [
      "Farben and the drug companies which it controlled in the United States through the Rockefeller interests were responsible for many inexplicable developments in the production and distribution of drugs"
    ],
    "type": "article-journal"
  },
  {
    "container-title": [
      "1920",
      "1926, I. G. merged with Dynamit-Nobel, the German branch of the dynamite firm, while an English firm took over the English division"
    ],
    "editor": [
      {
        "family": "G",
        "given": "I."
      }
    ],
    "note": [
      "I. G. officials then"
    ],
    "title": [
      "would become a potent weapon in the medical arsenal",
      "had signed working agreements with the important drug firms of Switzerland, Sandoz and Ciba-Geigy"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "victors",
        "particle": "prosecuted by the"
      },
      {
        "family": "I. G. Farben",
        "particle": "all of them connected with"
      },
      {
        "family": "acquitted",
        "particle": "including eleven officers of I. G. Eight were"
      },
      {
        "family": "Max Ilgner",
        "particle": "including"
      },
      {
        "family": "Harman Schmitz",
        "particle": "nephew of"
      },
      {
        "family": "C. G. Shake",
        "given": "Judge",
        "particle": "was"
      },
      {
        "family": "Al Minskoff",
        "particle": "the prosecuting attorney was"
      }
    ],
    "container-title": [
      "G. Farben was headlined by the Wall Street Journal on May 3,1988—GERMANY BEATS WORLD IN CHEMICAL SALES. Reporter Thomas F. O'Boyle listed the world's top five chemical companies in 1987 as 1",
      "The"
    ],
    "note": [
      "BASF $25.8 billion dollars 2. Bayer $23.6 billion dollars. 3. Hoechst $23.5"
    ],
    "title": [
      "Schmitz received the most severe sentence, eight years. Ilgner actually received three years, but the time was credited against his time in jail waiting for trial, and he was immediately released",
      "The survival of I"
    ],
    "type": "article-journal"
  }
]
